MATRIX COMMERCIALIZATION COLLABORATION AGREEMENT by and between MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC. (“MTF”) and ORTHOFIX HOLDINGS, INC. (“ORTHOFIX”)Matrix Commercialization Collaboration Agreement • March 2nd, 2010 • Orthofix International N V • Surgical & medical instruments & apparatus • Delaware
THIS MATRIX COMMERCIALIZATION COLLABORATION AGREEMENT (this “Agreement”) is dated as of July 24, 2008 and effective as of the Effective Date (as defined herein), by and between Musculoskeletal Transplant Foundation, Inc., a non-profit corporation formed under the laws of the District of Columbia, and having a principal place of business at 125 May Street, Suite 300, Edison, New Jersey 08837 (“MTF”), and Orthofix Holdings, Inc., a corporation organized under the laws of the State of Delaware, and having a principal place of business at 10115 Kincey Avenue, Suite 250, Huntersville, North Carolina 28078 (“Orthofix”) (each individually a “Party” and collectively the “Parties”).
AMENDMENT NO. 5 TO MATRIX COMMERCIALIZATION COLLABORATION AGREEMENTMatrix Commercialization Collaboration Agreement • March 14th, 2016 • Orthofix International N V • Surgical & medical instruments & apparatus
THIS AMENDMENT NO. 5 TO MATRIX COMMERCIALIZATION COLLABORATION AGREEMENT (this “Amendment”) is dated as of the date of the last signature hereunder and effective as of March 10, 2016 (the “Amendment Effective Date”) by and between Musculoskeletal Transplant Foundation, Inc., a non-profit corporation formed under the laws of the District of Columbia, and having a principal place of business at 125 May Street, Suite 300, Edison, New Jersey 08837 (“MTF”), and Orthofix Holdings, Inc., a corporation organized under the laws of the State of Delaware, and having a principal place of business at 3451 Plano Parkway, Lewisville, Texas 75056 (“Orthofix”) (each, individually, a “Party” and, collectively, the “Parties”).
AMENDMENT NO. 2 TO MATRIX COMMERCIALIZATION COLLABORATION AGREEMENTMatrix Commercialization Collaboration Agreement • May 1st, 2012 • Orthofix International N V • Surgical & medical instruments & apparatus
THIS AMENDMENT NO. 2 TO MATRIX COMMERCIALIZATION COLLABORATION AGREEMENT (this “Amendment No. 2”) is dated as of January 9, 2012 (the “Amendment No. 2 Effective Date”) by and between Musculoskeletal Transplant Foundation, Inc., a non-profit corporation formed under the laws of the District of Columbia, and having a principal place of business at 125 May Street, Suite 300, Edison, New Jersey 08837 (“MTF”), and Orthofix Holdings, Inc., a corporation organized under the laws of the State of Delaware, and having a principal place of business at 3451 Plano Parkway, Lewisville, Texas 75056 (“Orthofix”) (each individually a “Party” and collectively the “Parties”).
AMENDMENT NO. 6 TO MATRIX COMMERCIALIZATION COLLABORATION AGREEMENTMatrix Commercialization Collaboration Agreement • February 26th, 2018 • Orthofix International N V • Surgical & medical instruments & apparatus
THIS AMENDMENT NO. 6 TO MATRIX COMMERCIALIZATION COLLABORATION AGREEMENT (this “Amendment No. 6”) is dated as of December 29, 2017 (the “Amendment No. 6 Effective Date”) by and between Musculoskeletal Transplant Foundation, Inc., a non-profit corporation formed under the laws of the District of Columbia, and having a principal place of business at 125 May Street, Suite 300, Edison, New Jersey 08837 (“MTF”), and Orthofix Holdings, Inc., a corporation organized under the laws of the State of Delaware, and having a principal place of business at 3451 Plano Parkway, Lewisville, Texas 75056 (“Orthofix”) (each individually a “Party” and collectively the “Parties”).
AMENDMENT NO. 2 TO MATRIX COMMERCIALIZATION COLLABORATION AGREEMENTMatrix Commercialization Collaboration Agreement • February 29th, 2012 • Orthofix International N V • Surgical & medical instruments & apparatus
THIS AMENDMENT NO. 2 TO MATRIX COMMERCIALIZATION COLLABORATION AGREEMENT (this “Amendment No. 2”) is dated as of January 9, 2012 (the “Amendment No. 2 Effective Date”) by and between Musculoskeletal Transplant Foundation, Inc., a non-profit corporation formed under the laws of the District of Columbia, and having a principal place of business at 125 May Street, Suite 300, Edison, New Jersey 08837 (“MTF”), and Orthofix Holdings, Inc., a corporation organized under the laws of the State of Delaware, and having a principal place of business at 3451 Plano Parkway, Lewisville, Texas 75056 (“Orthofix”) (each individually a “Party” and collectively the “Parties”).
AMENDMENT NO. 3 TO MATRIX COMMERCIALIZATION COLLABORATION AGREEMENTMatrix Commercialization Collaboration Agreement • July 8th, 2013 • Orthofix International N V • Surgical & medical instruments & apparatus
THIS AMENDMENT NO. 3 TO MATRIX COMMERCIALIZATION COLLABORATION AGREEMENT (this “Amendment No. 3”) is dated as of June 25, 2013 (the “Amendment No. 3 Effective Date”) by and between Musculoskeletal Transplant Foundation, Inc., a non-profit corporation formed under the laws of the District of Columbia, and having a principal place of business at 125 May Street, Suite 300, Edison, New Jersey 08837 (“MTF”), and Orthofix Holdings, Inc., a corporation organized under the laws of the State of Delaware, and having a principal place of business at 3451 Plano Parkway, Lewisville, Texas 75056 (“Orthofix”) (each individually a “Party” and collectively the “Parties”).
